Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2024-04-04 00:00:00 ET · period of report 2024-04-04 · accession 0001415889-24-010279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-04 | 2024-04-04 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $232.37 | -6,000 | 36.7K | -14% | -$1.39M |
| D | 2024-04-04 | 2024-04-04 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +6,000 | 42.7K | +16% | +$706.6K |
| D | 2024-04-04 | 2024-04-04 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -6,000 | 48.0K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-04 | S | D | 3,279 | $232.55 | 37,957 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $231.96 to $232.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-04-04 | S | D | 1,041 | $233.64 | 36,916 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $233.00 to $233.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-04-04 | S | D | 1,374 | $230.99 | 41,236 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $230.65 to $231.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2024-04-04 | S | D | 100 | $228.84 | 42,610 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $228.56 to $229.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2024-04-04 | M | A | 6,000 | $117.76 | 42,710 | D | — | — | |
| 6 | Common | Common Stock | 2024-04-04 | S | D | 206 | $234.09 | 36,710 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $234.08 to $234.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Derivative | Stock Options | 2024-04-04 | M | D | 6,000 | $0.00 | 48,000 | D | $117.76 · 2021-03-15 to 2027-03-15 | 6,000 Common Stock |